Prolira BV has deltaScan to objectively detect delirium in an early stage improves patient care in hospitals.
Prolira BV is a high tech research and development SME and spin-off from the University Medical Center Utrecht, the Netherlands.Prolira BV has 2 founders, who together form the management team. The management team leads a technical team, a market introduction team and a clinical evaluation team, supported by an advisory board and an international clinical evaluation board consisting of three leading academic medical centers in Europe.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 1, 2022 | Series Unknown | €5M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ROM Utrecht Region | — | Series Unknown |